188 related articles for article (PubMed ID: 15160547)
1. Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis.
Samouilidou EC; Grapsa EJ; Kakavas I; Lagouranis A; Agrogiannis B
Int Urol Nephrol; 2003; 35(3):393-7. PubMed ID: 15160547
[TBL] [Abstract][Full Text] [Related]
2. Effect of dialysis on plasma total antioxidant capacity and lipid peroxidation products in patients with end-stage renal failure.
Samouilidou E; Grapsa E
Blood Purif; 2003; 21(3):209-12. PubMed ID: 12784045
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D
Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress and cardiovascular disease in dialyzed patients.
Usberti M; Gerardi GM; Gazzotti RM; Benedini S; Archetti S; Sugherini L; Valentini M; Tira P; Bufano G; Albertini A; Di Lorenzo D
Nephron; 2002 May; 91(1):25-33. PubMed ID: 12021516
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen metabolites: a link between oxidative stress and inflammation in patients on hemodialysis.
Samouilidou E; Grapsa E; Karpouza A; Lagouranis A
Blood Purif; 2007; 25(2):175-8. PubMed ID: 17215574
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
[TBL] [Abstract][Full Text] [Related]
8. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
[TBL] [Abstract][Full Text] [Related]
9. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
[TBL] [Abstract][Full Text] [Related]
10. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
[TBL] [Abstract][Full Text] [Related]
11. Linkage of some trace elements, peripheral blood lymphocytes, inflammation, and oxidative stress in patients undergoing either hemodialysis or peritoneal dialysis.
Guo CH; Wang CL; Chen PC; Yang TC
Perit Dial Int; 2011; 31(5):583-91. PubMed ID: 20592101
[TBL] [Abstract][Full Text] [Related]
12. Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease.
Sangeetha Lakshmi B; Harini Devi N; Suchitra MM; Srinivasa Rao PVLN; Siva Kumar V
Ren Fail; 2018 Nov; 40(1):534-540. PubMed ID: 30277113
[TBL] [Abstract][Full Text] [Related]
13. Relationship of serum cystatin C with C-reactive protein and apolipoprotein A1 in patients on hemodialysis.
Samouilidou EC; Grapsa E
Ren Fail; 2008; 30(7):711-5. PubMed ID: 18704820
[TBL] [Abstract][Full Text] [Related]
14. Cardiac troponin T and malondialdehyde modified plasma lipids in haemodialysis patients.
Scott B; Deman A; Peeters P; Van den Branden C; Stolear JC; Van Camp G; Verbeelen D
Nephrol Dial Transplant; 2003 Apr; 18(4):737-42. PubMed ID: 12637643
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function.
Huang JW; Yen CJ; Chiang HW; Hung KY; Tsai TJ; Wu KD
Am J Kidney Dis; 2004 Jun; 43(6):1047-55. PubMed ID: 15168385
[TBL] [Abstract][Full Text] [Related]
16. Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis.
Zwołińska D; Grzeszczak W; Szczepańska M; Kiliś-Pstrusińska K; Szprynger K
Pediatr Nephrol; 2006 May; 21(5):705-10. PubMed ID: 16518626
[TBL] [Abstract][Full Text] [Related]
17. The impact of chronic inflammation on bone turnover in hemodialysis patients.
Eleftheriadis T; Kartsios C; Antoniadi G; Kazila P; Dimitriadou M; Sotiriadou E; Koltsida M; Golfinopoulos S; Liakopoulos V; Christopoulou-Apostolaki M
Ren Fail; 2008; 30(4):431-7. PubMed ID: 18569918
[TBL] [Abstract][Full Text] [Related]
18. Effect of hemodialysis and peritoneal dialysis on redox status in chronic renal failure patients: a comparative study.
Mekki K; Taleb W; Bouzidi N; Kaddous A; Bouchenak M
Lipids Health Dis; 2010 Sep; 9():93. PubMed ID: 20815897
[TBL] [Abstract][Full Text] [Related]
19. Dialysis modality and nutritional status are associated with variability of inflammatory markers.
Snaedal S; Qureshi AR; Lund SH; Germanis G; Hylander B; Heimbürger O; Carrero JJ; Stenvinkel P; Bárány P
Nephrol Dial Transplant; 2016 Aug; 31(8):1320-7. PubMed ID: 27220753
[TBL] [Abstract][Full Text] [Related]
20. Reduced oxidative stress in hypoalbuminemic CAPD patients.
Kim SB; Yang WS; Min WK; Lee SK; Park JS
Perit Dial Int; 2000; 20(3):290-4. PubMed ID: 10898045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
